SanaDoleKaramMD

Physician

Dr. Karam is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
4921 Parkview Pl
Dept Oncology
Saint Louis, MO 63110
Phone+1 314-747-7236

Fax+1 314-362-8099

MedStar Health Georgetown UniversityResidency, Radiation Oncology, 2009 - 2013
MedStar Health/Georgetown-Washington Hospital CenterResidency, Internal Medicine, 2008 - 2009
Georgetown University School of MedicineClass of 2008

PubMed

Pushing the boundaries of radiotherapy-immunotherapy combinations: highlights from the 7immunorad conference.
Pierre-Antoine Laurent, Fabrice André, Alexandre Bobard, Desiree Deandreis, Sandra Demaria
Oncoimmunology. 2025-12-01
Proceedings of the National Cancer Institute Workshop on combining immunotherapy with radiotherapy: challenges and opportunities for clinical translation.
Zachary S Morris, Sandra Demaria, Arta M Monjazeb, Silvia C Formenti, Ralph R Weichselbaum
The Lancet. Oncology. 2025-03-01
Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HNSCC.
Khalid N M Abdelazeem, Diemmy Nguyen, Sophia Corbo, Laurel B Darragh, Mike W Matsumoto
Oncogene. 2025-02-01

Journal Articles

Association Between Lymph Node Ratio and Recurrence and Survival Outcomes in Patients with Oral Cavity Cancer
Ding Ding, Whitney Sumner, David Raben, Mohammad Hararah, Jessica McDermott, Sana D Karam, Julie Goddard, Hilary Somerset, JAMA
Final Report of a Phase I Trial of Olaparib with Cetuximab and Radiation for Heavy Smoker Patients with Locally Advanced Head and Neck Cancer
Hilary Somerset, Antonio Jimeno, David Raben, Sana D Karam, Dara L Aisner, Madeleine Kane, Carrie Marshall, Daniel W Bowles, Clinical Cancer Research
Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers
Sana D Karam, Dallin Milner, Hilary Somerset, Antonio Jimeno, David Raben, Clinical Cancer Research

Unique Treatment Can Eradicate Pancreatic Tumors While Stopping Cancer ProgressionApril 27th, 2023
Studying the Oral Cancer Immune Landscape in DogsMarch 21st, 2023
CU Anschutz Researchers Find Less Invasive Treatment for Some Head and Neck CancersNovember 29th, 2022
Join now to see all

Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCsUNIVERSITY OF COLORADO DENVER2019–2029
Tackling Treg mediated resistance to radiation and anti-PDL1 in HNSCCsUNIVERSITY OF COLORADO DENVER2019–2029
Sexual dimorphism and the immuno-modulatory role of estrogen signaling in HNSCCWASHINGTON UNIVERSITY2023–2028
Sexual dimorphism and the immuno-modulatory role of estrogen signaling in HNSCCWASHINGTON UNIVERSITY2023–2028
Sexual dimorphism and the immuno-modulatory role of estrogen signaling in HNSCCWASHINGTON UNIVERSITY2023–2028
Sexual dimorphism and the immuno-modulatory role of estrogen signaling in HNSCCWASHINGTON UNIVERSITY2023–2028
Role of EphB4-ephrin-B2 interaction in regulating crosstalk between cancer cell and vascular tumor microenvironment in head and neck cancerUNIVERSITY OF COLORADO DENVER2019–2025